Skip to main navigation Skip to search Skip to main content

Lymphocytes, but not CD34+ or CD33+ myeloid cells, of MDS patients have a hypermethylated CDKN2B promoter

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)16
    Number of pages1
    JournalBritish Journal of Haematology
    Volume129
    Publication statusPublished - 2005
    Event45th Annual Scientific Meeting of the British-Society-for-Haematology - Manchester, ENGLAND
    Duration: 11 Apr 200513 Apr 2005

    Cite this